Meeting slides EORTC-GI 2009

EORTC GI Winter course on Gastrointestinal Cancer, 4^th edition

DAY 1 – Friday February 27, 2009

Biology session

D. Aust, MD, PhD	EGFR and K-RAS testing: central lab? Local lab? Availability in Europe
E. Van Cutsem, MD, PhD	K-RAS and beyond

 
General session 1: Upper GI Cancers

F. Lordick, MD, PhD	Progress in gastric cancer therapy
A. Roth, MD	New strategies in pancreatic cancer
T. Greten, MD	Hepatocarcinoma: present and future directions
J.Y. Blay, MD, PhD	Strategy in GIST Tumor

DAY 2 – Saturday February 28, 2009

General session 2: Colorectal as a focus

D. Papamichael, MD	Adjuvant therapy for colon cancer: not forgetting the elderly patient
T. Ruers, MD, PhD	“Is there an optimal strategy for treating liver metastases from colorectal cancer?”
C. Rödel, MD	Rectal cancer update: current standards & new trends

General session 3

A. Sobrero, MD	Is there a best sequence to treat metastatic colon cancer?
S. Segaert, MD, PhD	Skin toxicity related to anti-EGFR treatment: which recommendations can be given?
A. Roth, MD	How do I manage the use of bevacizumab: anticoagulation? Which antihypertensives?

Closing lecture 3

E. van Cutsem, MD, PhD

From ASCO GI to WORLD GI: this year’s key areas of interest